A scientist and entrepreneur, Tim co-founded Allyx Therapeutics and serve as its Chief Operating Officer. He leads efforts across both Business Development and Research & Development, securing multiple grants and serving as the principal investigator of ongoing clinical research. Before Allyx, he was an inaugural Yale Blavatnik Fellow catalyzing the launch of multiple start-ups out of the university from within the technology transfer office, now Yale Ventures. By trade Tim is a chemist, specializing in peptide chemistry.